Financial Summary -
A & B Pharm Corporation S.r.l.
Unique identification code:16045190
Registration number:J22/438/2019
Nace:4773
Sales - Ron
2.282.018
Net Profit - Ron
86.327
Employees
17
Open Account
Company A & B Pharm Corporation S.r.l. with Fiscal Code 16045190
recorded a turnover of 2024 of
2.282.018,
with a net profit of
86.327
and having an average number of employees of
17.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
A & B Pharm Corporation S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
3.940.020
3.413.115
2.805.477
3.224.039
3.549.733
2.857.980
2.170.065
2.046.450
2.114.991
2.282.018
Total Income - EUR
3.948.840
3.418.944
2.860.049
3.442.966
3.735.611
3.781.982
2.892.591
2.046.456
2.115.092
2.321.495
Total Expenses - EUR
3.939.828
3.972.901
3.160.614
3.430.828
4.197.939
3.763.832
2.865.829
2.045.933
2.029.291
2.220.639
Gross Profit/Loss - EUR
9.012
-553.958
-300.565
12.138
-462.329
18.150
26.762
523
85.800
100.856
Net Profit/Loss - EUR
3.980
-553.958
-360.388
12.138
-462.329
18.150
26.762
523
65.532
86.327
Employees
80
70
45
48
44
28
20
21
21
17
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 8.5%, from 2.114.991 euro in the year 2023, to 2.282.018 euro in 2024.
The Net Profit increased by 21.161 euro, from 65.532 euro in 2023, to 86.327 in the last year.
Check the financial reports for the company - A & B Pharm Corporation S.r.l.
Financial Rating - A & B PHARM CORPORATION S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - A & B Pharm Corporation S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - A & B Pharm Corporation S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - A & B Pharm Corporation S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
A & B Pharm Corporation S.r.l. - CUI 16045190
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
2.132.578
2.131.130
1.967.430
1.642.930
1.474.495
697.284
421.891
400.825
394.260
375.725
Current Assets
1.403.350
847.628
858.669
1.214.075
1.486.484
1.107.947
1.043.125
1.235.196
1.179.612
1.515.439
Inventories
973.262
324.832
378.880
405.296
528.665
487.344
223.653
282.144
272.187
345.599
Receivables
262.404
212.123
325.669
559.970
600.108
445.767
476.918
652.280
830.536
1.098.394
Cash
167.684
310.674
154.120
248.808
357.711
174.836
342.554
300.772
76.889
71.446
Shareholders Funds
916.485
416.870
49.427
60.658
265.039
278.165
417.530
419.348
371.295
520.711
Social Capital
119.738
123.456
121.366
119.139
137.905
135.291
132.290
132.701
132.298
131.559
Debts
2.629.554
2.583.912
2.796.328
2.817.602
2.733.842
1.564.249
1.083.845
1.253.144
1.238.937
1.370.453
Income in Advance
7.795
4.768
1.996
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
1.515.439 euro in 2024 which includes Inventories of
345.599 euro, Receivables of
1.098.394 euro and cash availability of
71.446 euro.
The company's Equity was valued at
520.711 euro, while total Liabilities amounted to
1.370.453 euro.
Equity increased by 151.491 euro, from 371.295 euro in 2023, to 520.711 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - A & B Pharm Corporation S.r.l.